Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study

Journal of Nutrition

Volumn 135, Issue 3, 2005, Pages 397-403

  Tai, E Shyong ^a,c   Corella, Dolores ^a,d   Demissie, Serkalem ^e   Cupples, L Adrienne ^e   Coltell, Oscar ^a   Schaefer, Ernst J ^a   Tucker, Katherine L ^b   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d UNIVERSITY OF VALENCIA   (Spain)

^e BOSTON UNIVERSITY   (United States)

Author keywords

PPARA, gene nutrient interaction; PUFA; Triglycerides

Indexed keywords

APOLIPOPROTEIN C3; LEUCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; VALINE;

ADULT; AGED; ALLELE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; FAT INTAKE; FEMALE; GENE CONTROL; GENE INTERACTION; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; LIPID METABOLISM; MALE; POPULATION; TRANSACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 14944384748     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.3.397     Document Type: Article

References (35)

1. Salati, L. M., Szeszel-Fedorowicz, W., Tao, H., Gibson, M. A., Amir-Ahmady, B., Stabile, L. P. & Hodge, D. L. (2004) Nutritional regulation of mRNA processing. J. Nutr. 134: 2437S-2443S.
2. Benatti, P., Peluso, G., Nicolai, R. & Calvani, M. (2004) Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 23: 281-302.
3. Price, P. T., Nelson, C. M. & Clarke, S. D. (2000) Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr. Opin. Lipidol. 11: 3-7.
4. Sessler, A. M. & Ntambi, J. M. (1998) Polyunsaturated fatty acid regulation of gene expression. J. Nutr. 128: 923-926.
5. Fruchart, J. C., Duriez, P. & Staels, B. (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10: 245-257.
6. Vohl, M. C., Lepage, P., Gaudet, D., Brewer, C. G., Betard, C., Perron, P., Houde, G., Cellier, C., Faith, J. M., Despres, J. P., Morgan, K. & Hudson, T. J. (2000) Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J. Lipid Res. 41: 945-952.
7. Sapone, A., Peters, J. M., Sakai, S., Tomita, S., Papiha, S. S., Dai, R., Friedman, F. K. & Gonzalez, F. J. (2000) The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 10: 321-333.
8. Flavell, D. M., Pineda-Torra, I., Jamshidi, Y., Evans, D., Diamond, J. R., Elkeles, R. S., Bujac, S. R., Miller, G., Talmud, P. J., Staels, B. & Humphries, S. E. (2000) Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43: 673-680.
9. Lacquemant, C., Lepretre, F., Pineda-Torra, I., Manraj, M., Charpentier, G., Ruiz, J., Staels, B. & Froguel, P. (2000) Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab. 26: 393-401.
10. Jump, D. B. (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13: 155-164.
11. Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W., Schaefer, E. J. & Ordovas, J. M. (2002) Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 22: 805-810.
12. Wijendran, V. & Hayes, K. C. (2004) Dietary (n-6) and (n-3) fatty acid balance and cardiovascular health. Annu. Rev. Nutr. 24: 597-615.
13. Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M. & Castelli, W. P. (1975) The Framingham Offspring Study. Design and preliminary data. Prev. Med. 4: 518-525.
14. Ordovas, J. M, Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. & Schaefer, E. J. (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler. Thromb. Vasc. Biol. 20: 1323-1329.
15. Anonymous (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
16. Cupples, L. A., Gagnon, D. R. & Kannel, W. B. (1992) Long- and short-term risk of sudden coronary death. Circulation 85: 111-118.
17. Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J. & Walker, J. A. (1998) Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18: 1046-1053.
18. Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B. & Willett, W. C. (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 135: 1114-1126; discussion 1127-1136.
19. Hunter, D. J., Rimm, E. B., Sacks, F. M., Stampfer, M. J., Colditz, G. A., Litin, L. B. & Willett, W. C. (1992) (1992) Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am. J. Epidemiol. 135: 418-427.
20. Hertz, R., Bishara-Shieban, J. & Bar-Tana, J. (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
21. Shachter, N. S. (2001) Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12: 297-304.
22. Robitaille, J., Brouillette, C., Houde, A., Lemieux, S., Perusse, L., Tchernof, A., Gaudet, D. & Vohl, M. C. (2004) Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J. Hum. Genet. 49: 482-489.
23. Bouly, M., Masson, D., Gross, B., Jiang, X. C., Fievet, C., Castro, G., Tall, A. R., Fruchart, J. C., Staels, B., Lagrost, L. & Luc, G. (2001) Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J. Biol. Chem. 276: 25841-25847.
24. Clarke, S. D. (2004) The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15: 13-18.
25. Pawar, A. & Jump, D. B. (2003) Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 278: 35931-35939.
26. Zheng, X., Rivabene, R., Cavallari, C., Napolitano, M., Avella, M., Bravo, E. & Botham, K. M. (2002) The effects of chylomicron remnants enriched in n-3 or n-6 polyunsaturated fatty acids on the transcription of genes regulating their uptake and metabolism by the liver: influence of cellular oxidative state. Free Radic. Biol. Med. 32: 1123-1131.
27. Clarke, S. D., Thuillier, P., Baillie, R. A. & Sha, X. (1999) Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am. J. Clin. Nutr. 70: 566-571.
28. Clarke, S. D. (2001) Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J. Nutr. 31: 1129-1132.
29. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G. & Wahli, W. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779-791.
30. Svaneborg, N., Moller, J. M., Schmidt, E. B., Varming, K., Lervang, H. H. & Dyerberg, J. (1994) The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids 29: 145-147.
31. Dyerberg, J., Eskesen, D. C., Andersen, P. W., Astrup, A., Buemann, B., Christensen, J. H., Clausen, P., Rasmussen, B. F., Schmidt, E. B., Tholstrup, T., Toft, E., Toubro, S. & Stender, S. (2004) Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur. J. Clin. Nutr. 58: 1062-1070.
32. Finnegan, Y. E., Minihane, A. M., Leigh-Firbank, E. C., Kew, S., Meijer, G. W., Muggli, R., Calder, P. C. & Williams, C. M. (2003) Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 77: 783-795.
33. Harris, W. S. (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (suppl.): 1645S-1654S.
34. Beynen, A. C. & Katan, M. B. (1985) Why do polyunsaturated fatty acids lower serum cholesterol? Am. J. Clin. Nutr 42: 560-563.
35. Hayes, K. C. (2000) Dietary fatty acids, cholesterol, and the lipoprotein profile. Br. J. Nutr. 84: 397-399.